Shahin Fesharaki

Title: Shahin Fesharaki: Innovator in Pharmaceutical Formulations

Introduction

Shahin Fesharaki is a notable inventor based in Weston, FL (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oral dosage forms for various medications. With a total of 3 patents to his name, Fesharaki's work has the potential to impact the treatment of serious health conditions.

Latest Patents

One of Fesharaki's latest patents is focused on oral dosage forms of ibrutinib. This patent describes stable and bioavailable oral dosage forms that include ibrutinib and an acidifying agent. The formulations can also incorporate additional components such as a binder, surfactant, lubricant, filler, and/or disintegrant. This innovation aims to improve the methods of treating cancers, particularly blood cancers, and graft versus host disease by administering a dosage form that effectively delivers ibrutinib to patients in need.

Another significant patent by Fesharaki is for a modified release tranexamic acid formulation. This invention presents a modified release dosage form designed for the oral administration of tranexamic acid. These advancements in pharmaceutical formulations demonstrate Fesharaki's commitment to enhancing patient care through innovative drug delivery systems.

Career Highlights

Throughout his career, Shahin Fesharaki has worked with reputable companies in the pharmaceutical industry. Notably, he has been associated with Actavis, Inc. and Hikma Pharmaceuticals USA Inc. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical formulations.

Collaborations

Fesharaki has collaborated with talented professionals in the field, including Mayank Joshi and Mahmoud Ghannam. These collaborations have likely enriched his work and fostered innovation in pharmaceutical research and development.

Conclusion

Shahin Fesharaki is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly improve treatment options for patients. His innovative patents reflect his dedication to advancing healthcare through effective drug delivery systems.